株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオテクノロジーの世界市場 (ナノバイオテクノロジー・DNAシーケンシング・発酵・組織再生・セルベースアッセイ):分析・シェア・動向・規模・予測

Biotechnology Market, By Technology (PCR, NanoBiotechnology, DNA Sequencing, Fermentation, Tissue Regeneration, and Cell-Based Assay), By Application and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

発行 AnalystView Market Insights 商品コード 737913
出版日 ページ情報 英文 140 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
バイオテクノロジーの世界市場 (ナノバイオテクノロジー・DNAシーケンシング・発酵・組織再生・セルベースアッセイ):分析・シェア・動向・規模・予測 Biotechnology Market, By Technology (PCR, NanoBiotechnology, DNA Sequencing, Fermentation, Tissue Regeneration, and Cell-Based Assay), By Application and Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
出版日: 2018年03月17日 ページ情報: 英文 140 Pages
概要

当レポートでは、世界におけるバイオテクノロジー市場の現状と見通しについて調査分析し、各種市場影響因子の分析、各セグメント・地域別による市場分析と予測、競合環境、および主要事業者のプロファイルなど、体系的な情報を提供しています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 主な市場動向

  • 市場成長促進要因
  • 市場成長抑制要因
  • 市場機会
  • 市場の将来動向

第4章 産業調査

  • ポーターのファイブフォース分析
  • 市場魅力度の分析
  • 規制の枠組みの分析

第5章 市場情勢

  • 市場シェア分析

第6章 バイオテクノロジー市場:技術別

  • 概要
  • ポリメラーゼ連鎖反応
  • ナノバイオテクノロジー
  • DNAシーケンシング
  • 発酵
  • 組織再生
  • セルベースアッセイ
  • その他 (クロマトグラフィーなど)

第7章 バイオテクノロジー市場:用途別

  • 概要
  • バイオサービス
  • バイオ医薬非
  • バイオ産業
  • バイオ農業

第8章 バイオテクノロジー市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋 (APAC)
  • その他 (RoW)

第9章 主要ベンダーの分析

  • AstraZeneca
  • Biogen
  • Abbott
  • Merck
  • Novartis AG

第10章 アナリストの見解

第11章 付録

図表

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PEST Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Biotechnology Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • Table 10 Biotechnology Market, by Technology, 2014 - 2025 (USD Billion)
  • Table 11 Biotechnology Market, by Application, 2014 - 2025 (USD Billion)
  • Table 12 Biotechnology Market, by Geography, 2014 - 2025 (USD Billion)
  • Table 13 North America Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 14 U.S. Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 15 Canada Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 16 Europe Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 17 France Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 18 Germany Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 19 Asia Pacific Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 20 China Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 21 India Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 22 Latin America Biotechnology Market, 2014 - 2025 (USD Billion)
  • Table 23 MEA Biotechnology Market, 2014 - 2025 (USD Billion)

List of Figures

  • Figure 1 Research Methodology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Value Chain Analysis Analysis
  • Figure 6 Biotechnology Market, by Technolgy, 2014 - 2025 (USD Billion)
  • Figure 7 Biotechnology Market, by Application, 2014 - 2025 (USD Billion)
  • Figure 8 Biotechnology Market, by Geography, 2014 - 2025 (USD Billion)
目次
Product Code: AV165

Report Hightlights

The biotechnology market is estimated to represent a global market of USD 403.8 billion by 2017 with growth rate of 10.9%.

Market Dynamics

Biotechnology industry covers the study of living organisms to develop or modify new products for a specific purpose. Increasing research and development activities coupled with rising investment by key players in this market is driving the market growth significantly. Furthermore, the growth is attributed to the favorable government initiatives to promote biotech field across the globe. As per the various research publications, currently, more than 250 biotechnology vaccines and products are commercially available and is projected to increase at a significant rate. On contrary, the high cost of biopharmaceuticals coupled with the strict regulatory environment has been acknowledged as a major restraining factor for this industry

Technology Takeaway

In terms of technology, the global biotechnology market is categorized as PCR, NanoBiotechnology, DNA Sequencing, Fermentation, Tissue Regeneration, Cell-Based Assay, and others. Of which, tissue regeneration segment achieved the highest share of the total market, accounted for more than USD 75 billion in 2017. It refers to the method of combining biological active molecule with scaffold/cells into functional tissue. Tissue engineering and regeneration exhibit strong potential in the skeletal reconstruction of large bone defects as well as gene-based therapies. Cartilage and artificial skin are some of the examples of tissue regeneration and engineered products approved by the U.S. FDA. Currently, several research activities are undergoing to develop high-throughput assays and instruments in order to reduce the complexity, time, and cost of tissue engineering. In addition to medical applications, non-therapeutic applications of this method include tissue chips that can be used to test toxicity and development of biosensors.

Application Takeaway

Application segment is divided into Bioservices, Biopharmacy, Bioindustrial, and Bio-agriculture. Biopharmacy captured the highest (almost 60% share through the study period) share of the global biotechnology industry. Further, this segment appears to be growing at a strong rate over the future period. The bio-agriculture application is estimated to grow at significant CAGR owing to the advancement in crop harvesting techniques coupled with the commercialization of biotech crops. For example, according to the International Service for the Acquisition of Agri-Biotech Applications, in 2016, around 18 million farmers have planted 185.1 million hectares of biotech crops were in 26 countries which were almost 110 fold increase compared to the 1.7 million hectares planting in 1996.

Regional Takeaway

Regionally, developed regions such as North America and Europe accounted for the highest share of the global industry. Increasing research and development activities coupled with growing demand for effective pharmaceuticals drive the regional growth. For example, as per the Pharmaceutical Research and Manufacturers Association (PhRMA), the U.S. firms conduct over half of the world's R&D activities in the pharma sector and hold the intellectual property rights (IPR) on most of the new therapeutics.

Asia Pacific region is pegged to register a 15.6% growth rate in terms of value. A country such as India and China's billion-plus population offers huge growth potential for biotechnology products and services. Moreover, increasing budgetary allocations for the biotech industry in these countries further provide a healthy platform for market growth. While the biotech industry is on a high growth trajectory in Asia Pacific countries, the overall market remains small in African countries owing to the fragile backbone of the country's healthcare infrastructure and a shortage of skilled professionals.

Key Vendor Takeaway

Companies such as AstraZeneca, Biogen, Abbott, Merck, and Novartis AG are studies in detail along with the attributes such as company overview, financial performance, and key developments. Key companies are engaged in expanding their market presence through strategic mergers and acquisitions to capture large customer base. For instance, in August 2016, Novartis announced to the expansion of its biotechnology facility in Huningue, France. Such expansion has helped the company to boost its monoclonal antibody production by 70%.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2014 & 2016

Base Year - 2017

Estimated Year - 2018

Projected Year - 2025

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Hospitals

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TECHNOLOGY

PCR

NanoBiotechnology

DNA Sequencing

Fermentation

Tissue Regeneration

Cell-Based Assay

Others

MARKET, BY APPLICATION

Bioservices

Biopharmacy

Bioindustrial

Bio-agriculture

MARKET, BY REGION

North America

U.S.

Canada

Europe

Germany

France

Rest of Europe

Asia Pacific

India

China

Rest of APAC

Rest of the World

Middle East and Africa

Latin America

TABLE OF CONTENTS

1. BIOTECHNOLOGY MARKET OVERVIEW

  • 1.1. Study Scope
  • 1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Key Market Facts
  • 2.2. Geographical Scenario
  • 2.3. Companies in the Market

3. BIOTECHNOLOGY KEY MARKET TRENDS

  • 3.1. Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Future Trends

4. BIOTECHNOLOGY INDUSTRY STUDY

  • 4.1. Porter's Analysis
  • 4.2. Market Attractiveness Analysis
  • 4.3. Regulatory Framework Analysis

5. BIOTECHNOLOGY MARKET LANDSCAPE

  • 5.1. Market Share Analysis

6. BIOTECHNOLOGY MARKET - BY TECHNOLOGY

  • 6.1. Overview
  • 6.2. Polymerase Chain Reaction
    • 6.2.1. Overview
    • 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.3. NanoBiotechnology
    • 6.3.1. Overview
    • 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.4. DNA Sequencing
    • 6.4.1. Overview
    • 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.5. Fermentation
    • 6.5.1. Overview
    • 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.6. Tissue Regeneration
    • 6.6.1. Overview
    • 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.7. Cell-Based Assay
    • 6.7.1. Overview
    • 6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 6.8. Others (Chromatography etc.)
    • 6.8.1. Overview
    • 6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

7. BIOTECHNOLOGY MARKET - BY APPLICATION

  • 7.1. Overview
  • 7.2. Bioservices
    • 7.2.1. Overview
    • 7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.3. Biopharmacy
    • 7.3.1. Overview
    • 7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.4. Bioindustrial
    • 7.4.1. Overview
    • 7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 7.5. Bio-agriculture
    • 7.5.1. Overview
    • 7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

8. BIOTECHNOLOGY MARKET- BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Overview
    • 8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.2.3. U.S.
    • 8.2.3.1. Overview
    • 8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.2.4. Canada
    • 8.2.4.1. Overview
    • 8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.3. Europe
    • 8.3.1. Overview
    • 8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.3. France
    • 8.3.3.1. Overview
    • 8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.4. Germany
    • 8.3.4.1. Overview
    • 8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.3.5. Rest of Europe
    • 8.3.5.1. Overview
    • 8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.4. Asia Pacific (APAC)
    • 8.4.1. Overview
    • 8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.3. China
    • 8.4.3.1. Overview
    • 8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.4. India
    • 8.4.4.1. Overview
    • 8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.4.5. Rest of APAC
    • 8.4.5.1. Overview
    • 8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
  • 8.5. Rest of the World
    • 8.5.1. Overview
    • 8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.5.3. Latin America
    • 8.5.3.1. Overview
    • 8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)
    • 8.5.4. Middle East and Africa
    • 8.5.4.1. Overview
    • 8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Billion)

9. KEY VENDOR ANALYSIS

  • 9.1. AstraZeneca
    • 9.1.1. Company Overview
    • 9.1.2. SWOT Analysis
    • 9.1.3. Key Developments
  • 9.2. Biogen
    • 9.2.1. Company Overview
    • 9.2.2. SWOT Analysis
    • 9.2.3. Key Developments
  • 9.3. Abbott
    • 9.3.1. Company Overview
    • 9.3.2. SWOT Analysis
    • 9.3.3. Key Developments
  • 9.4. Merck
    • 9.4.1. Company Overview
    • 9.4.2. SWOT Analysis
    • 9.4.3. Key Developments
  • 9.5. Novartis AG
    • 9.5.1. Company Overview
    • 9.5.2. SWOT Analysis
    • 9.5.3. Key Developments

Client can request additional company profiling as per specific requirements

10. 360 DEGREE ANALYSTVIEW

11. APPENDIX

  • 11.1. Research Methodology
  • 11.2. Abbreviations
  • 11.3. Disclaimer
  • 11.4. Contact Us
Back to Top